rs139306706

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_138694.4(PKHD1):​c.9215C>T​(p.Ala3072Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 1,613,972 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A3072A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0010 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 8 hom. )

Consequence

PKHD1
NM_138694.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:10

Conservation

PhyloP100: 0.508
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012168914).
BP6
Variant 6-51748401-G-A is Benign according to our data. Variant chr6-51748401-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 96440.We mark this variant Likely_benign, oryginal submissions are: {Benign=5, Likely_benign=2, Uncertain_significance=1}. Variant chr6-51748401-G-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PKHD1NM_138694.4 linkuse as main transcriptc.9215C>T p.Ala3072Val missense_variant 58/67 ENST00000371117.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PKHD1ENST00000371117.8 linkuse as main transcriptc.9215C>T p.Ala3072Val missense_variant 58/671 NM_138694.4 P2P08F94-1
PKHD1ENST00000340994.4 linkuse as main transcriptc.9215C>T p.Ala3072Val missense_variant 58/615 A2P08F94-2

Frequencies

GnomAD3 genomes
AF:
0.00105
AC:
159
AN:
152122
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.0127
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000720
Gnomad OTH
AF:
0.00192
GnomAD3 exomes
AF:
0.00211
AC:
530
AN:
251036
Hom.:
2
AF XY:
0.00248
AC XY:
337
AN XY:
135650
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000579
Gnomad ASJ exome
AF:
0.0125
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00859
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000934
Gnomad OTH exome
AF:
0.00229
GnomAD4 exome
AF:
0.00125
AC:
1820
AN:
1461732
Hom.:
8
Cov.:
34
AF XY:
0.00149
AC XY:
1086
AN XY:
727164
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.000761
Gnomad4 ASJ exome
AF:
0.0140
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00863
Gnomad4 FIN exome
AF:
0.0000562
Gnomad4 NFE exome
AF:
0.000479
Gnomad4 OTH exome
AF:
0.00182
GnomAD4 genome
AF:
0.00104
AC:
159
AN:
152240
Hom.:
2
Cov.:
32
AF XY:
0.00126
AC XY:
94
AN XY:
74428
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.000589
Gnomad4 ASJ
AF:
0.0127
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.0104
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000720
Gnomad4 OTH
AF:
0.00190
Alfa
AF:
0.00153
Hom.:
1
Bravo
AF:
0.000903
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.00207
AC:
251
EpiCase
AF:
0.00109
EpiControl
AF:
0.00119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:10
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024PKHD1: BP4, BS2 -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 03, 2020This variant is associated with the following publications: (PMID: 22995991, 15805161) -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Autosomal recessive polycystic kidney disease Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Jun 30, 2017- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 07, 2016- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 09, 2021Variant summary: PKHD1 c.9215C>T (p.Ala3072Val) results in a non-conservative amino acid change located in the Right handed beta helix domain (IPR039448) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0021 in 251036 control chromosomes, predominantly at a frequency of 0.0086 within the South Asian subpopulation in the gnomAD database, including 2 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 1.2 fold of the estimated maximal expected allele frequency for a pathogenic variant in PKHD1 causing Polycystic Kidney And Hepatic Disease phenotype (0.0071), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. Although c.9215C>T has been reported in sequencing studies and databases (example, Bergmann_2005), to our knowledge, no occurrence of c.9215C>T in individuals affected with Polycystic Kidney And Hepatic Disease and no experimental evidence demonstrating its impact on protein function have been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (Benign, n=2; VUS, n=1). Based on the evidence outlined above, the variant was classified as benign. -
PKHD1-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesMar 29, 2021This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Polycystic kidney disease 4 Benign:1
Likely benign, criteria provided, single submitterclinical testingPars Genome LabMay 18, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
6.6
DANN
Benign
0.97
DEOGEN2
Benign
0.17
T;.
Eigen
Benign
-0.57
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.052
N
LIST_S2
Benign
0.62
T;T
M_CAP
Benign
0.056
D
MetaRNN
Benign
0.012
T;T
MetaSVM
Benign
-0.67
T
MutationAssessor
Benign
1.9
L;L
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.27
Sift
Benign
0.048
D;T
Sift4G
Benign
0.069
T;T
Polyphen
0.63
P;B
Vest4
0.086
MVP
0.80
MPC
0.063
ClinPred
0.0099
T
GERP RS
0.28
Varity_R
0.040
gMVP
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139306706; hg19: chr6-51613199; API